Biomedical engineering is an exciting, diverse discipline that uses technology and engineering to solve medical and biological problems, inventing new equipment, materials, methods and processes to safely and accurately diagnose patients, improve medical treatment and its outcomes.
Responsible for innovations ranging from prosthetic limbs and heart valves, to tissue and stem cell research and biomedical signal processing, latest advances include brain-controlled prosthesis, 3D printing of human organs, remote surgery and disease fighting nanorobots.
Bringing together medicine, biological science and engineering, our MSc is both clinically and industry-focused, building on our internationally-leading reputation for regenerative medicine, medical engineering and longstanding expertise in medical devices. It covers a broad range of topics – nanotechnology in medicine, smart materials, biomaterials, prosthetics and rehabilitation, through to management of medical equipment in hospitals.
Based in the Guy Hilton Research Centre, you’ll have access to cutting-edge multi-disciplinary research into specialist and novel areas of regenerative medicine with the opportunity to conduct an in-depth research project alongside our world-class researchers.
Our proximity to the University Hospital means you’ll be able to see physiological monitors and diagnostic instrumentation being used and serviced. This could include anything from electroencephalograms (EEG), electrocardiograms (ECG) or electromyography (EMG) to anaesthetic machines or kidney dialysis.
You will be taught by staff with real world experience of developing and commercialising medical products, in particular, technological innovations that have improved the treatment of fractures and spinal injuries for thousands of patients.
You’ll also have the opportunity to conduct an in-depth research project into specialist and novel areas of biomedical and clinical engineering, working alongside our leading researchers who are actively investigating ways in which tissue engineering and associated technologies can aid the treatment of cardiovascular diseases, and the potential to use nanotechnology to control cell behaviour in neurodegenerative diseases, such as Parkinson’s.
As part of the Versus Arthritis Tissue Engineering and Regenerative Therapies Centre, researchers here at Keele are also pioneering cell therapy treatments to regenerate damaged bones, joints and muscles in patients with osteoarthritis and rheumatoid arthritis.